TITLE

Early Recognition of Alpha-1 Antitrypsin Deficiency and Considerations for Liver Transplantation

AUTHOR(S)
Tzakis, Andreas
PUB. DATE
February 2013
SOURCE
Gastroenterology & Hepatology;Feb2013, Vol. 9 Issue 2, p110
SOURCE TYPE
Academic Journal
DOC. TYPE
Interview
ABSTRACT
An interview with doctor Andreas Tzakis, director of Transplant Center at Cleveland Clinic Florida in Weston, Florida. He mentions the role and underlying causes of alpha-1 antitrypsin deficiency. He says that alpha-1 antitrypsin deficiency affects the liver and lungs causing emphysema of the lungs and liver cirrhosis. He also discusses the importance of early recognition of the deficiency in relation to treatment.
ACCESSION #
86417697

 

Related Articles

  • Alpha-1 Antitrypsin Deficiency Panniculitis. Konvalinka, Patricia Ann // Dermatology Nursing;Nov/Dec2010, Vol. 22 Issue 6, p23 

    The article offers information related to alpha-1 antitrypsin (AAT) deficiency-associated panniculitis. It examines the potential causes, symptoms, testing and therapeutic options for panniculitis. It investigates various effects of therapies for alpha-1 antitrypsin deficiency (AATD) such as...

  • Treatment Options for the Alpha-1 Patient. Sandhaus, Robert A. // AARC Times;Feb2011, Vol. 35 Issue 2, p32 

    In this article the author comments on treatment options for alpha-1 antitrypsin deficiency (alpha-1) in the U.S. The author mentions that alpha-1 is a major cause of chronic obstructive pulmonary disease (COPD). He believes that alpha-1 deficiency is treated by accurately diagnosing the disease...

  • Alpha-1-antitrypsin deficiency. Wise, Matt; Chapman, Stephen // Pulse;Oct2015, p86 

    The article discusses the genetic disorder, Alpha-i-antitrypsin deficiency (AiATD) and the ways to detect it. The article mentions the epidemiology, symptoms and signs and diagnosis of the disease. It also mentions the worst possible outcomes which includes respiratory failure and death or liver...

  • Decreased glutathione and low catalase activity contribute to oxidative stress in children with α-1 antitrypsin deficiency. Escribano, Amparo; Amor, Mónica; Pastor, Sara; Castillo, Silvia; Sanz, Francisco; Codoñer-Franch, Pilar; Dasí, Francisco // Thorax;Jan2015, Vol. 70 Issue 1, p82 

    Background Recent investigations in animal models have revealed oxidative stress and oxidative damage in the pathogenesis of alpha-1 antitrypsin deficiency (AATD). However, no data are available on the oxidative stress status and antioxidant enzyme activity in these patients. This study was...

  • Emerging Role of the Respiratory Therapist and the Diagnosis of Alpha-1 Antitrypsin Deficiency. Stoller, James K. // AARC Times;Jan2012, Vol. 36 Issue 1, p11 

    The article discusses the important role of respiratory therapist (RT) in establishing diagnosis and managing patients with alpha-1 antitrypsin deficiency (AATD). It notes that common interventions and treatments for chronic obstruction pulmonary disease (COPD) including tobacco-dependence...

  • The Alpha-1 Association Genetic Counseling Program: An Innovative Approach to Service. McGee, Dawn; Strange, Charlie; McClure, Rebecca; Schwarz, Laura; Erven, Marlene // Journal of Genetic Counseling;Aug2011, Vol. 20 Issue 4, p330 

    In an era of specialty medicine, genetic counselors are becoming increasingly focused in their service provision. The Alpha-1 Association Genetic Counseling Program, established in September 2007, specializes in confidential toll-free genetic counseling provided by a certified genetic counselor...

  • A novel model and molecular therapy for Z alpha-1 antitrypsin deficiency. McNab, Gillian; Dafforn, Timothy; Wood, Alice; Sapey, Elizabeth; Stockley, Robert // Mammalian Genome;Apr2012, Vol. 23 Issue 3/4, p241 

    Animal models that closely resemble human disease can present a challenge. Particularly so in alpha-1 antitrypsin deficiency (αATD), as the mouse alpha-1 antitrypsin (αAT) cluster encodes five highly related genes compared with the one in humans. The mouse PI2 homologue is closest to the...

  • Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency alleles. Donato, L. J.; Karras, R. M.; Katzmann, J. A.; Murray, D. L.; Snyder, M. R. // Respiratory Research;9/5/2015, Vol. 16 Issue 1, p1 

    Background: Alpha-1-antitrypsin (A1AT) deficiency disease results from mutations in the A1AT gene. Controversy exists in regards to treatment of heterozygous carriers of the S and Z deficiency alleles. Quantitation of allelic expression has not been possible with standard laboratory methods....

  • Testing for AIpha-1 Antitrypsin Deficiency in a Pulmonary Rehabilitation Setting. Naegele, Valerie; Persinger, Rebecca // AARC Times;Oct2012, Vol. 36 Issue 10, p32 

    The article discusses the importance of testing for Alpha-1 Antitrypsin deficiency (AAT) in individuals with chronic obstructive pulmonary disorder (COPD). AAT deficiency may have a role to play in the etiology of COPD. The pulmonary rehabilitation program at Tri-city Medical Center in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics